blank
blank

ICH E22 Guideline on general considerations for patient preference studies

1:1
Open for consultation from 12 December to 12 April, this draft ICH guideline sets out how to design and submit robust patient preference studies to inform regulatory decision‑making across a medicine’s lifecycle.

This harmonised draft guideline explains how patient preference studies (PPS) can be designed, conducted, analysed and submitted to support drug development and regulatory evaluation, including benefit–risk assessment and maintenance of approvals. It clarifies that PPS generate structured insights into what matters most to patients when weighing treatment attributes such as outcomes, risks and other relevant characteristics, and provides general methodological considerations intended to improve the quality and usability of patient preference information in regulatory contexts.

Acces this publication
Publication cover image

Year of publication

2025

Source

European Medicines Agency (EMA)

Author

You might also be interested in

ERDERA Accelerator webinar (1)

ERDERA launches Ethics & Regulatory webinar series with introductory webinar on ethics across the research continuum

ERDERA’s ethics and regulatory experts are launching a dedicated webinar series to help the rare disease research community navigate two fast-moving areas of biomedical research: Advanced Therapy Medicinal Products (ATMPs) and Artificial Intelligence.
webinar series ERDERA

Introductory webinar: Situating ethics in the research continuum

July 24 @ 3:00 pm - 4:00 pm
This webinar will present a theoretical framework for situating ethics across research activities. The framework will then be brought to life through a relevant case study discussion, giving participants a concrete reference point for the episodes ahead.
State of the art rare disease country reports ERDERA

State of the art 2026 rare disease country report: Poland

This 2026 country report outlines the policy, research, care and support landscape for rare diseases in Poland.
NMG workshop 2026

ERDERA National Mirror Groups workshop: Creating, evolving and utilising national registries to advance rare disease research

Held in Riga on 9–10 June, the workshop brought National Mirror Group experts, researchers, clinicians and policymakers together to exchange practical lessons on how national rare disease registries can better support research and alignment across countries.

ERDERA's

search form